Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
Trials
; 21(1): 1033, 2020 Dec 29.
Article
in En
| MEDLINE
| ID: mdl-33375932
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2020
Document type:
Article
Affiliation country:
Belgium
Country of publication:
United kingdom